| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0002-9610(00)00366-4 |
| P698 | PubMed publication ID | 10930495 |
| P2093 | author name string | H R Rosen | |
| K G Benner | |||
| J M Rabkin | |||
| C L Corless | |||
| K D Flora | |||
| A J Olyaei | |||
| S L Oroloff | |||
| P2860 | cites work | Seroconversion to human herpesvirus 6 following liver transplantation is a marker of cytomegalovirus disease | Q73851382 |
| Is liposomal amphotericin B (ambisome) an effective prophylaxis of mycotic infections after liver transplantation? | Q74686148 | ||
| Clinical significance of viral load in the diagnosis of cytomegalovirus disease after liver transplantation | Q74725270 | ||
| Liposomal amphotericin B prevents invasive fungal infections in liver transplant recipients. A randomized, placebo-controlled study | Q33490295 | ||
| Orthotopic liver transplantation in high-risk patients: risk factors associated with mortality and infectious morbidity | Q34275352 | ||
| Fungal infections in liver transplant recipients | Q34561594 | ||
| Infections Following Orthotopic Liver Transplantation | Q36406743 | ||
| Fungus Infections After Liver Transplantation | Q40786598 | ||
| Fungal infections in solid-organ transplantation | Q40914902 | ||
| Infectious complications in liver transplantation | Q42143989 | ||
| The independent role of cytomegalovirus as a risk factor for invasive fungal disease in orthotopic liver transplant recipients. Boston Center for Liver Transplantation CMVIG-Study Group. Cytogam, MedImmune, Inc. Gaithersburg, Maryland. | Q42662774 | ||
| Randomized trial of fluconazole versus nystatin for the prophylaxis of Candida infection following liver transplantation. | Q43759182 | ||
| Bacterial and fungal infections after liver transplantation: an analysis of 284 patients | Q44012293 | ||
| Human herpesvirus 6 seronegativity before transplantation predicts the occurrence of fungal infection in liver transplant recipients | Q44054825 | ||
| Clinical spectrum of fungal infections after orthotopic liver transplantation | Q44572653 | ||
| Risk factors for systemic fungal infections in liver transplant recipients | Q44841235 | ||
| Risk factors of invasive Candida and non-Candida fungal infections after liver transplantation. | Q51194161 | ||
| Risk factors for invasive fungal infections complicating orthotopic liver transplantation. | Q51195234 | ||
| Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplantation--a prospective, randomized, double-blind study. | Q54171057 | ||
| Factors associated with the development of candidemia and candidemia-related death among liver transplant recipients | Q70881574 | ||
| Prognostic significance and risk factors of untreated cytomegalovirus viremia in liver transplant recipients | Q70916666 | ||
| Invasive aspergillosis in liver transplant recipients: association with candidemia and consumption coagulopathy and failure of prophylaxis with low-dose amphotericin B | Q72720477 | ||
| Invasive fungal infections in liver transplant recipients receiving tacrolimus as the primary immunosuppressive agent | Q73255296 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 426-430 | |
| P577 | publication date | 2000-05-01 | |
| P1433 | published in | The American Journal of Surgery | Q15762745 |
| P1476 | title | Association of fungal infection and increased mortality in liver transplant recipients | |
| P478 | volume | 179 |
| Q45064378 | Allograft tolerance induced by donor apoptotic lymphocytes requires phagocytosis in the recipient. |
| Q35101150 | British Society for Medical Mycology proposed standards of care for patients with invasive fungal infections |
| Q54511639 | Disseminated Cryptococcus neoformans var. grubii infections in intensive care units. |
| Q37044673 | Disseminated cryptococcosis in HIV-uninfected patients. |
| Q44595697 | Efficacy and safety of itraconazole prophylaxis for fungal infections after orthotopic liver transplantation: a prospective, randomized, double-blind study |
| Q37203082 | Hepatic and renal artery rupture due to Aspergillus and Mucor mixed infection after combined liver and kidney transplantation: a case report |
| Q44468410 | Impaired phagocyte respiratory burst responses to opportunistic fungal pathogens in transplant recipients: in vitro effect of r-metHuG-CSF (Filgrastim). |
| Q80783433 | Incidence of fungal infections in a solid organ recipients dedicated intensive care unit |
| Q38822708 | Infectious Complications After Liver Transplantation |
| Q33719829 | Invasive Candida Infections in Liver Transplant Recipients: Clinical Features and Risk Factors for Mortality |
| Q40136622 | Iron-Related Markers are Associated with Infection after Liver Transplantation. |
| Q59400769 | Lethal infection by candida (Torulopsis) incospicua complicating orthotopic liver transplantation |
| Q57815117 | Management of bacterial and fungal infections in end stage liver disease and liver transplantation: Current options and future directions |
| Q80676337 | Microsatellite DNA identification and genotyping of Candida albicans from Lebanese clinical isolates |
| Q36953823 | Once weekly fluconazole for antifungal prophylaxis post-liver transplantation |
| Q55424061 | Regulated Cell Death as a Therapeutic Target for Novel Antifungal Peptides and Biologics. |
| Q36739864 | Regulation of the Candida albicans cell wall damage response by transcription factor Sko1 and PAS kinase Psk1 |
| Q44319235 | Successful living donor liver transplantation in a patient with preoperative fungal infection |
| Q35746388 | The Impact of Opportunistic Infections on Clinical Outcome and Healthcare Resource Uses for Adult T Cell Leukaemia |
| Q44842818 | The economic costs to United States hospitals of invasive fungal infections in transplant patients |
| Q37810091 | Voriconazole: a broad-spectrum triazole for the treatment of invasive fungal infections |
Search more.